A. D. Degli Antoni

发表

HCV–HIV coinfected pregnant women: data from a multicentre study in Italy

G. Guaraldi, E. Tamburrini, A. Maccabruni, 2016, Infection.

HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): a three year study.

L. Calza, M. Re, V. Sambri, 2016, The new microbiologica.

Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

C. Giaquinto, R. Badolato, F. Parazzini, 2018, The Journal of antimicrobial chemotherapy.

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

D. Francisci, L. Monno, R. Bucciardini, 2012, The Journal of antimicrobial chemotherapy.

Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy

E. Ferrazzi, G. Guaraldi, E. Tamburrini, 2006, Epidemiology and Infection.

Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry

A. d’Arminio Monforte, M. Zazzi, D. Francisci, 2020, Open forum infectious diseases.

Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance.

M. Floridia, S. Baroncelli, M. Pirillo, 2020, Journal of infection in developing countries.

Pregnancy Outcomes in HIV-Infected Women of Advanced Maternal Age

G. Guaraldi, E. Tamburrini, A. Maccabruni, 2013, HIV clinical trials.

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.

G. Guaraldi, E. Tamburrini, M. Regazzi, 2006, British journal of clinical pharmacology.

Multifocal phaeohyphomycosis caused by Exophiala xenobiotica in a kidney transplant recipient

P. Le Pape, U. Maggiore, A. Vaglio, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey.

A. Giacomelli, F. Gobbi, A. Calcagno, 2022, The new microbiologica.

Brief Report: Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women With HIV Laboratory and Clinical Outcomes in an Observational National Study

G. Guaraldi, E. Tamburrini, G. Liuzzi, 2018, Journal of acquired immune deficiency syndromes.

Clinical features of hepatitis delta virus infection in a northern italian

G. Pasetti, C. Ferrari, A. Penna, 2005, Infection.

Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis

F. Foschi, F. Conti, M. Merli, 2017, Journal of viral hepatitis.

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

G. d’Ettorre, A. Antinori, C. Mussini, 2019, PloS one.

Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.

G. Guaraldi, E. Tamburrini, M. Floridia, 2015, AIDS research and human retroviruses.

Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study.

D. Francisci, E. Tamburrini, P. Martinelli, 2014, The Journal of antimicrobial chemotherapy.

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

G. Guaraldi, E. Tamburrini, V. Savasi, 2020, Infection.

HIV‐1 DNA dynamics and variations in HIV‐1 DNA protease and reverse transcriptase sequences in multidrug‐resistant patients during successful raltegravir‐based therapy

D. Francisci, O. Cirioni, A. Cara, 2016, Journal of medical virology.

Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia.

A. Musolino, A. Ardizzoni, D. Pezzuolo, 2007, Haematologica.

COVID-19 in kidney transplant recipients

U. Maggiore, L. Peruzzi, E. Fiaccadori, 2020, American Journal of Transplantation.

Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy

L. Calza, M. Re, P. Viale, 2018, Infectious diseases.

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.

G. d’Ettorre, R. Bellagamba, G. Guaraldi, 2013, The Journal of antimicrobial chemotherapy.

HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy

G. Guaraldi, E. Tamburrini, P. Martinelli, 2017, HIV clinical trials.

Relationship Between Health-Related Quality of Life Measures and High HIV Viral Load in HIV-Infected Triple-Class-Experienced Patients

R. Bellagamba, G. Guaraldi, D. Francisci, 2014, HIV clinical trials.

Integrated treatment of the severely injured patient with coexistent comorbidities. A case report and literature review.

G. Cervellin, M. Magotti, A. Pedrazzini, 2015, Acta bio-medica : Atenei Parmensis.

Good prenatal detection rate of major birth defects in HIV‐infected pregnant women in Italy

I. Cetin, P. Mastroiacovo, E. Tamburrini, 2015, Prenatal diagnosis.

CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy

C. Giaquinto, R. Badolato, F. Parazzini, 2021, Infection.